// App-Quantinova.ai

1730 : Decanucleotide Insertion Polymorphism of F7 Influences Significantly the Risk of Thrombosis in Patients with Essential Thrombocythemia

Researchers

Presenter

  • Damla Olcaydu

Principal Investigators

  • Bettina Gisslinger

  • Martin Schalling

  • Sophie Frantal

  • Juergen Thiele

  • Leonhard Mullauer

  • Hans-Michael Kvasnicka

  • Robert Kralovics

  • Heinz Gisslinger

Medical Centers

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  • CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Institute of Pathology University of Frankfurt/M, Frankfurt/M, Germany.

  • Center for Medical Statistics, Medical University of Vienna, Vienna, Austria

  • Department of Clinical Pharmacology, Medical University of Vienna, Austria

Locations

  • Germany

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Venous thrombosis

  • Myelofibrosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Carvedilol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved